Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors (Q46327011)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 October 2008

edit

Language	Label	Description	Also known as
English	Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors	scientific article published on 7 October 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

title

Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

author

Augustinus A M Hart

series ordinal

4

object named as

Augustinus A M Hart

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

author name string

Catharina M Korse

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

Johannes M G Bonfrer

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

Neil K Aaronson

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

Babs G Taal

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

publication date

7 October 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

published in

Neuroendocrinology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

volume

89

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

page(s)

296-301

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

Identifiers

DOI

10.1159/000162876

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

PubMed publication ID

18840995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18840995

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18840995

ResearchGate publication ID

23305390

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46327011&oldid=2247022449"